Opportunity: Co-founder Role in Digital Health (East Africa – Clinical Background Required)

[Ditiro Rampate]

Good day SisonkeBiotik Community,

I want to share an opportunity that aligns strongly with our collective interests in Artificial Intelligence, healthcare innovation, and impact across Africa.

A company called N23 Health is currently building artificial intelligence-driven solutions to improve early breast cancer detection in low-resource settings. Their focus is on addressing gaps in access to screening and diagnostics, particularly in healthcare systems where resources and specialist capacity are limited.

They are seeking a Kenyan-based co-founder with a clinical background, specifically in oncology or women’s health, to lead their operations across East Africa, including Kenya, Rwanda, and Ethiopia.

From the information shared, this is a deeply operational and strategic role that involves:

• Engaging with Ministries of Health and national cancer programs
• Navigating regulatory approval processes across multiple countries
• Building partnerships with hospitals, non-governmental organizations, and funders
• Supporting pilot deployments and scaling solutions into real-world healthcare environments
• Contributing to product, clinical, and go-to-market strategy

In terms of profile, they are looking for someone who:

• Has a medical or clinical background with relevant domain expertise
• Understands how healthcare systems function in East Africa
• Can operate effectively in complex, early-stage environments
• Is willing to take on ownership as part of a founding team

Regarding structure and compensation, this is an early-stage company. The role begins with a consulting or part-time retainer during the pilot phase, transitioning to a full-time salaried position once funding is secured. The role includes equity, reflecting its co-founder nature.

As part of basic due diligence:

• The organization presents itself as an early-stage digital health company, which implies a higher level of uncertainty and execution risk compared to established institutions
• Their work focuses on a high-need problem area (breast cancer detection in low-resource settings), which is well-aligned with global health priorities
• The model of combining Artificial Intelligence with clinical workflows in such environments is promising, but success typically depends heavily on regulatory navigation, data quality, and integration into existing health systems
• Interested individuals are encouraged to engage directly with the team to better understand their technology, validation approach, partnerships, and funding status before making any commitments

If this opportunity is relevant to you or someone in your network, you can reach out directly:

Email: li...@n23.life
Website: www.n23.health

As always, I encourage anyone interested to approach this with curiosity and careful evaluation, while recognizing the potential for meaningful impact in this space. I have attached more info.

Warm regards,

SisonkeBiotik Leadership
Ditiro Rampate